|
TMEM123 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.618000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.956300E-02 |
| Normal-vs-Stage2 |
8.404400E-02 |
| Normal-vs-Stage3 |
1.068840E-01 |
| Normal-vs-Stage4 |
4.614800E-01 |
| Stage1-vs-Stage2 |
5.776200E-01 |
| Stage1-vs-Stage3 |
8.720600E-01 |
| Stage1-vs-Stage4 |
2.937800E-01 |
| Stage2-vs-Stage3 |
5.222400E-01 |
| Stage2-vs-Stage4 |
2.404800E-01 |
| Stage3-vs-Stage4 |
4.404000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.704800E-03 |
| Normal-vs-AfricanAmerican |
1.746450E-01 |
| Normal-vs-Asian |
5.799200E-01 |
| Caucasian-vs-AfricanAmerican |
7.92020000000004E-05 |
| Caucasian-vs-Asian |
2.866400E-01 |
| AfricanAmerican-vs-Asian |
9.253400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.087900E-02 |
| Normal-vs-Female |
1.276030E-01 |
| Male-vs-Female |
6.138600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.572400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.304300E-02 |
| Normal-vs-Age(61-80Yrs) |
4.731500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.869800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.745600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.166400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.964400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.248200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.039600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.669800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.635600E-01 |
| Normal-vs-Grade 2 |
2.721100E-03 |
| Normal-vs-Grade 3 |
3.028000E-01 |
| Normal-vs-Grade 4 |
6.543400E-01 |
| Grade 1-vs-Grade 2 |
7.333000E-01 |
| Grade 1-vs-Grade 3 |
5.356800E-01 |
| Grade 1-vs-Grade 4 |
5.316000E-01 |
| Grade 2-vs-Grade 3 |
1.232280E-02 |
| Grade 2-vs-Grade 4 |
3.766400E-02 |
| Grade 3-vs-Grade 4 |
7.253400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.023500E-03 |
| Normal-vs-ccB subtype |
3.284400E-02 |
| ccA subtype-vs-ccB subtype |
3.540000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.126000E-02 |
| Normal-vs-N1 |
5.781600E-01 |
| N0-vs-N1 |
8.180000E-01 |
|
|
